In this study, we report the successful creation of the APP/PS1/htau AD mouse model that develops plaque deposition and tau hyperphosphorylation by expressing wildtype human tau and humanized Aβ without the overexpression of mutant APP or PS1. This evidence concerns the gene APP and Alzheimer disease.